Literature DB >> 12834700

Facial necrotizing fasciitis following acute dacryocystitis.

Pei Wen Lin1, Hsin Ching Lin.   

Abstract

PURPOSE: To report a case of progressive necrotizing fasciitis of the face following acute dacryocystitis.
DESIGN: Interventional case report.
METHODS: A 60-year-old woman presented with left acute dacryocystitis with abscess formation that had ruptured; a small wound remained. Erythematous swelling of the left eyelid and face developed 3 days later. Clinical progression and computed tomographic findings led to the diagnosis of necrotizing fasciitis with abscess formation. Early intravenous antibiotics and repeated surgical debridements were performed.
RESULTS: Soft tissue necrosis was found the fascial planes extending deep to the maxilla bone and periorbital fat. The patient was successfully treated without ocular, orbital, or facial complications.
CONCLUSIONS: Necrotizing fasciitis of the eyelid and face progresses rapidly. Early diagnosis, prompt intravenous antibiotic administration, and aggressive surgical debridement will prevent the associated morbidity and mortality.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12834700     DOI: 10.1016/s0002-9394(03)00089-8

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  3 in total

1.  Outcome of transcanalicular laser dacryocystorhinostomy with endonasal augmentation in acute versus post-acute dacryocystitis.

Authors:  Ruchi Goel; Charu Sagar; Smriti Nagpal Gupta; Shalin Shah; Ayushi Agarwal; Priyanka Golhait; Sushil Kumar; Raut Akash
Journal:  Eye (Lond)       Date:  2022-05-19       Impact factor: 3.775

2.  Periorbital necrotizing fasciitis accompanied by sinusitis and intracranial epidural abscess in an immunocompetent patient.

Authors:  Su Youn Suh; Jung Hyo Ahn
Journal:  Int J Ophthalmol       Date:  2022-05-18       Impact factor: 1.779

3.  Management of facial necrotizing fasciitis.

Authors:  Christian Schurr; M Burghartz; T Miethke; M Kesting; N Hoang; R Staudenmaier
Journal:  Eur Arch Otorhinolaryngol       Date:  2008-11-29       Impact factor: 2.503

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.